Fagron Group Revenue and Competitors

USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Fagron Group's estimated annual revenue is currently $283M per year.(i)
  • Fagron Group's estimated revenue per employee is $201,000

Employee Data

  • Fagron Group has 1408 Employees.(i)
  • Fagron Group grew their employee count by 16% last year.

Fagron Group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
COOReveal Email/Phone
3
VP, Quality and RegulatoryReveal Email/Phone
4
SVP, General Counsel - North AmericaReveal Email/Phone
5
Global supplier quality officerReveal Email/Phone
6
Director ITReveal Email/Phone
7
Global ESG OfficerReveal Email/Phone
8
Global Innovations DirectorReveal Email/Phone
9
Global IT DirectorReveal Email/Phone
10
Global Legal & Governmental Affairs DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$91.7M4567%N/AN/A
Add Company

What Is Fagron Group?

Fagron's mission is to optimize and innovate personalized pharmaceutical care. \n\nFagron was founded in the Netherlands (Rotterdam) in 1990. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron obtained market leadership in pharmaceutical compounding. Today, our team develops, innovates and produces innovative concepts, products and formulas for compounding pharmacies, prescribers and patients in 35 countries worldwide.\n\nMore than 2.600 employees are located in offices, compounding facilities and plants in Fagron's key regions Benelux, Europe, North America, South America and the Pacific. The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam.

keywords:N/A

N/A

Total Funding

1408

Number of Employees

$283M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fagron Group News

2022-04-17 - Global Cancer Supportive Care Drugs Market 2022 Research ...

Fagron Group; Teva Pharmaceuticals Industries; F.Hoffmann La-Roche Ltd; Apr Applied Pharma Science Research; Acacia Pharma; Kyowa Hakko Kirin...

2022-04-17 - Compounding Pharmacies Market Growth in Future Scope 2022 ...

... Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, ... and represented by a group of specialists through the application of...

2022-03-22 - Fagron NV (EBR:FAGR) institutional owners may be pleased with recent gains after 14% loss over the past year

The group holding the most number of shares in the company, around 64% to be precise, is institutions. That is, the group stands to benefit the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$276M14080%N/A
#2
$414.2M1409N/AN/A
#3
$484.3M14127%N/A
#4
$448.7M1412N/AN/A
#5
$574.1M141414%N/A